Skip to content
OpenCapital
Get started

SELLAS Life Sciences Group, Inc. SLS Shares (Diluted)

Shares (Diluted) at other companies

Pfizer logo
PfizerPFE
5.7B+0.4%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
88.3M+2.4%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Immunome logo
ImmunomeIMNM
113.1M+42.5%
Arcus Biosciences logo
Arcus BiosciencesRCUS
125.4M+27.4%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
162.2M+43.1%

Other financials

Income statement

See full
Revenue-—
Gross profit-—
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.78B+674%
Enterprise value$1.68B+826%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%—

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0×0.0×
Current ratio17.2×+12.6×

Where this comes from

Reported directly by SELLAS Life Sciences Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s shares (diluted)?
SELLAS Life Sciences Group, Inc. (SLS) reported shares (diluted) of 172.5M in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s shares (diluted) changed year-over-year?
SELLAS Life Sciences Group, Inc.'s shares (diluted) increased by 96.5% year-over-year, from 87.8M to 172.5M.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s shares (diluted) has grown at a 60.1% compound annual growth rate (CAGR), from 61.5M to 403.8M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.